Natural History and Outcome Measures in Alexander Disease



Status:Recruiting
Healthy:No
Age Range:Any
Updated:10/10/2018
Start Date:January 2016
End Date:December 2026
Contact:Amy Waldman, MD
Phone:215-590-1719

Use our guide to learn which trials are right for you!

The purpose of this study is to define the natural history of Alexander Disease, a
leukodystrophy that causes neurological dysfunction. Investigators will obtain clinical
outcome assessments to measure how the disease affects a patient's gross motor, fine motor,
speech and language function, swallowing, and quality of life. The data obtained from this
study will be used for the design of future treatment trials.

Participants will be asked to complete physical examinations including physical therapy,
occupational therapy, speech and language therapy, and swallowing assessments. Patients (or
caretakers) may be asked to complete questionnaires as well. The study asks for participants
to return at least once yearly to repeat assessments.

Inclusion Criteria:

- Diagnosed with Alexander Disease

Exclusion Criteria:

- Other Leukodystrophies will not be enrolled
We found this trial at
1
site
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Amy T Waldman, MD, MSCE
Phone: 267-425-2063
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials